Original Research

Attention-Deficit/Hyperactivity Disorder in a VA Polytrauma Clinic

Fed Pract. 2015 February;32(2):14-20

References

1. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N Engl J Med. 2008;358(5):453-463.

2. Screening and Evaluation of Possible Traumatic Brain Injury in Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) Veterans. Washington, DC: Dept of Veterans Affairs; 2010. VHA Directive 2010-012.

3. Polytrauma System of Care. Washington, DC: Dept of Veterans Affairs; 2013. VHA Handbook 1172.01.

4. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723.

5. Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis. Br J Psychiatry. 2009;194(3):204-211.

6. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190(5):402-409.

7. Krauss MR, Russell RK, Powers TE, Li Y. Accession standards for attention-deficit/hyperactivity disorder: A survival analysis of military recruits, 1995-2000. Mil Med. 2006;171(2):99-102.

8. Vanderploeg RD, Belanger HG, Horner RD, et al. Health outcomes associated with military deployment: Mild traumatic brain injury, blast, trauma, and combat associations in the Florida National Guard. Arch Phys Med Rehabil. 2012;93(11):1887-1895.

9. Theeler BJ, Flynn FG, Erickson JC. Headaches after concussion in US soldiers returning from Iraq or Afghanistan. Headache. 2010;50(8):1262-1272.

10. Sayer NA, Chiros CE, Sigford B, et al. Characteristics and rehabilitation outcomes among patients with blast and other injuries sustained during the Global War on Terror. Arch Phys Med Rehabil. 2008;89(1):163-170.

11. Sayer NA, Rettmann NA, Carlson KF, et al. Veterans with history of mild traumatic brain injury and posttraumatic stress disorder: Challenges from provider perspective. J Rehabil Res Dev. 2009;46(6):703-716.

12. Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: A systematic review. JAMA. 2008;300(6):711-719.

13. Halbauer JD, Ashford JW, Zeitzer JM, Adamson MM, Lew HL, Yesavage JA. Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury. J Rehabil Res Dev. 2009;46(6):757-796.

14. Romesser J, Shen S, Reblin M, et al. A preliminary study of the effect of a diagnosis of concussion on PTSD symptoms and other psychiatric variables at the time of treatment seeking among veterans. Mil Med. 2011;176(3):246-252.

15. Cicerone KD, Kalmar K. Persistent postconcussion syndrome: The structure of subjective complaints after mild traumatic brain injury. J Head Trauma Rehabil. 1995;10(3):1-17.

16. Weathers FW, Huska JA, Keane TM. PCL-C for DSM-IV. Boston, MA: National Center for PTSD–Behavioral Science Division; 1991.

17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR). 4th ed. Washington, DC: American Psychiatric Association; 2000.

18. Hanson JA, Haub MD, Walker JJ, Johnston DT, Goff BS, Dretsch MN. Attention deficit hyperactivity disorder subtypes and their relation to cognitive functioning, mood states, and combat stress symptomatology in deploying U.S. soldiers. Mil Med. 2012;177(6):655-662.

19. Visser SN, Danielson ML, Bitsko RH, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry. 2014;53(1):34-46.e2.

20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Washington, DC: American Psychiatric Association; 2013.

21. Barkley, RA, Murphy KR, Fischer M. ADHD in Adults: What the Science Says. New York, NY: Guilford Press; 2008.

22. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res. 2007;38(1):113-128.

23. Shelley-Tremblay JF, Rosén LA. Attention deficit hyperactivity disorder: An evolutionary perspective. J Genet Psychol. 1996;157(4):443-453.

24. Jensen PS, Mrazek D, Knapp PK, et al. Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation. J Am Acad Child Adolesc Psychiatry. 1997;36(12):1672-1679.

To better understand the treatment needs of young veterans returning home from the wars in Iraq and Afghanistan, this study sought to identify the prevalence rate of ADHD, a condition known to complicate community adjustment. In this study, there was a 10.6% prevalence of ADHD among the 690 OEF/OIF/OND combat veterans seen over the 5-year period in the CJZVAMC PC, which is substantially higher than prevalence estimates in the U.S. general population but similar to estimates in previous military samples.

Compared with veterans who did not have ADHD, veterans with ADHD were younger, less well educated, and reported more problems with attention and concentration but did not have a greater incidence of military TBI or mental health comorbidities. The high prevalence of ADHD in this group argues for greater awareness of this clinical variable and development of intervention programs tailored to the specific skill deficiencies found in the condition, which can be included as part of the comprehensive treatment interventions.

Veterans with ADHD treated in the PC seem to benefit from structured treatment plans and education to promote self-awareness and veteran-centered self-management for effective symptom reduction and coping strategies. Development of effective integrated treatment options with a focus on educational and vocational resources and assistance could facilitate successful community reintegration. Future studies are needed to further assess outcomes of community reintegration, including academic and occupational outcomes, in this population.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.